The analysis of preferences of obstetrician-sgynecologists and therapists of Belgorod region in heartburn and constipation treatment in pregnant women in comparison with all-russian data

Authors

  • Natalya A. Chuhareva FGBU Scientific Center for Obstetrics, Gynecology and Perinatology
  • Roman A. Bontsevich Belgorod National Research University; Multidisciplinary clinic "Harmony Health" - the center of the safe pharmacotherapy pregnant and nursing
  • Roza M. Esayan Research Center for Obstetrics, Gynecology and Perinatology; Ministry of Health Russia
  • Kristina V. Shchurovskaya Belgorod National Research University
  • A. V. Lysenko Belgorod National Research University

Abstract

Summary. One of the most frequent accompanying pathologies during pregnancy – digestive tract diseases. The work purpose - to analyse the choice of medicinal therapy among doctors at heartburn and constipation treatment during pregnancy. Materials and methods - the analysis of anonymous questioning within carrying out the second stage of the All-Russian pharmacoepidemiological research "Epidemiology of medicines use in pregnant women" which was carried out from February to April, 2015 The comparison of the received results with results of questioning of doctors of Belgorod region was executed on the basis of received data. Results and discussion. About a half of doctors chooses for heartburn treatment in pregnant women antacids medicines, and also inhibitors of a proton pomp (omeprazole). To 10% of doctors prescribe insufficiently studied blockers of H2-histamine receptors. In constipation therapy more than 60% of doctors voted for salt laxative a lactulose. Less than 11% of doctors prescribed to patients unsafe medicines of senna and macrogol. Conclusion. The analysis of doctors’ answers on tactics of medicinal therapy purpose at heartburn and constipation during pregnancy has shown that more than 68% of the practicing experts appoint the therapy, based on rational use of medicines.

Keywords:

pregnancy, heartburn, constipation, lactulose, antacids medicines, inhibitors of a proton pomp, rational pharmacotherapy

Author Contribution

Natalya A. Chuhareva, FGBU Scientific Center for Obstetrics, Gynecology and Perinatology

FGBU Scientific Center for Obstetrics, Gynecology and Perinatology. Academician VI Kulakov Russian Ministry of Health, Moscow, Russia

Roman A. Bontsevich, Belgorod National Research University; Multidisciplinary clinic "Harmony Health" - the center of the safe pharmacotherapy pregnant and nursing

Belgorod National Research University, dep. pharmacology; Multidisciplinary clinic "Harmony Health" - the center of the safe pharmacotherapy pregnant and nursing, Belgorod, Russia

Roza M. Esayan, Research Center for Obstetrics, Gynecology and Perinatology; Ministry of Health Russia

PhD, Head of the Therapeutic Department of the Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health Russia, Moscow, Russia

Kristina V. Shchurovskaya, Belgorod National Research University

Belgorod National Research University, dep. pharmacology, Belgorod, Russia

A. V. Lysenko, Belgorod National Research University

Belgorod National Research University, dep. Pharmacology, Belgorod, Russia

Published

30-12-2016

How to Cite

Chuhareva NA, Bontsevich RA, Esayan RM, Shchurovskaya KV, Lysenko AV (2016) The analysis of preferences of obstetrician-sgynecologists and therapists of Belgorod region in heartburn and constipation treatment in pregnant women in comparison with all-russian data. Research Results in Pharmacology 2(4): 68–72

Issue

Section

Review article

Most read articles by the same author(s)